The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Recardio; SynDevRx
Consulting or Advisory Role - AI Therapeutics
Results of a completed phase I study of LAM-002 (apilimod dimesylate), a first-in-class phosphatidylinositol-3-phosphate 5 kinase (PIKfyve) inhibitor, administered as monotherapy or with rituximab or atezolizumab to patients with previously treated follicular lymphoma or other B-cell cancers.
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Genentech/Roche; Janssen; Merck; MorphoSys; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); LAM Therapeutics (Inst); MEI Pharma (Inst); Merck (Inst); Millennium (Inst); Roche/Genentech (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Jonathan B Cohen
Consulting or Advisory Role - Genentech/Roche; Gilead Sciences; Janssen; Seagen
Research Funding - AI Therapeutics; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Hutchison MediPharma; Seagen; Takeda; Unum Therapeutics
 
Wael A. Harb
Research Funding - AI Therapeutics
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Loretta J. Nastoupil
Honoraria - Bayer; Celgene; Gamida Cell; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Novartis; Pfizer; Spectrum Pharmaceuticals; TG Therapeutics
Research Funding - Celgene; Genentech/Roche; Janssen Biotech; Karus Therapeutics; LAM Therapeutics; TG Therapeutics
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Alimera Sciences; Alimera Sciences; Bayer; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; MorphoSys; Novartis; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); Seagen (Inst)
 
Nehal J. Lakhani
Consulting or Advisory Role - Innovent Biologics
Research Funding - Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); Apexian Pharmaceuticals (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Coordination Therapeutics (Inst); CytomX Therapeutics (Inst); Formation Biologics (Inst); Forty Seven (Inst); Incyte (Inst); InhibRx (Inst); Innovent Biologics (Inst); Jounce Therapeutics (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Northern Biologics (Inst); Pfizer (Inst); Regeneron (Inst); Symphogen (Inst); TaiRx, Inc. (Inst); Tesaro (Inst)
 
Marshall T. Schreeder
Research Funding - AI Therapeutics
 
Taimur Sher
Consulting or Advisory Role - Akcea Therapeutics
Research Funding - AI Therapeutics; Akcea Therapeutics; AstraZeneca
 
Dipti Patel-Donnelly
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); LAM Therapeutics (Inst); Roche (Inst)
 
David Michael Aboulafia
Research Funding - AI Therapeutics (Inst)
 
Candace A. Fuchs
Employment - AI Therapeutics
Stock and Other Ownership Interests - AI Therapeutics; Alexion Pharmaceuticals; Pfizer
 
Darrell Nix
No Relationships to Disclose
 
Sean Landrette
Employment - AI Therapeutics
Patents, Royalties, Other Intellectual Property - AI Therapeutics
 
Patricia S Graham
Employment - CE3
 
Lydia B King
Employment - CE3
 
Peter L. Young
Employment - AI Therapeutics
Stock and Other Ownership Interests - AI Therapeutics; Zenith Epigenetics
 
Langdon L. Miller
Employment - Cleveland BioLabs; VelosBio
Leadership - Cleveland BioLabs; VelosBio
Stock and Other Ownership Interests - Abbvie; AI Therapeutics; AstraZeneca; Cancer Genetics; Cleveland BioLabs; Epithany; Gilead Sciences; VelosBio
Consulting or Advisory Role - AI Therapeutics; Incuron
Patents, Royalties, Other Intellectual Property - Gilead Sciences; PTC Therapeutics; VelosBio
Travel, Accommodations, Expenses - Cleveland BioLabs; Incuron; VelosBio
 
Henri Lichenstein
Employment - AI Therapeutics
Leadership - AI Therapeutics
Stock and Other Ownership Interests - AI Therapeutics
Patents, Royalties, Other Intellectual Property - AI Therapeutics
 
Sarah C. Rutherford
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; HERON; Juno Therapeutics; Karyopharm Therapeutics; Seagen; Verastem
Research Funding - Genentech (Inst); Karyopharm Therapeutics (Inst); LAM Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst)